Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Anders Hallberg

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Concepts & Ideas

Chemicals & Drugs

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Bäck Marcus; Nyhlén Jonas; Kvarnström Ingemar; Appelgren Sara; Borkakoti Neera; Jansson Katarina; Lindberg Jimmy; Nyström Susanne; Hallberg Anders; Rosenquist Sa; Samuelsson Bertil
Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.
Wallinder Charlotta; Botros Milad; Rosenström Ulrika; Guimond Marie-Odile; Beaudry Hélène; Nyberg Fred; Gallo-Payet Nicole; Hallberg Anders; Alterman Mathias
Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships.
Wu Xiongyu; Ohrngren Per; Ekegren Jenny K; Unge Johan; Unge Torsten; Wallberg Hans; Samuelsson Bertil; Hallberg Anders; Larhed Mats
Two-carbon-elongated HIV-1 protease inhibitors with a tertiary-alcohol-containing transition-state mimic.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Anders Hallberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Bäck Marcus; Nyhlén Jonas; Kvarnström Ingemar; Appelgren Sara; Borkakoti Neera; Jansson Katarina; Lindberg Jimmy; Nyström Susanne; Hallberg Anders; Rosenquist Sa; Samuelsson Bertil
Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.
Bioorganic & medicinal chemistry 2008;16(21):9471-86.
2008: Wallinder Charlotta; Botros Milad; Rosenström Ulrika; Guimond Marie-Odile; Beaudry Hélène; Nyberg Fred; Gallo-Payet Nicole; Hallberg Anders; Alterman Mathias
Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships.
Bioorganic & medicinal chemistry 2008;16(14):6841-9.
2008: Wu Xiongyu; Ohrngren Per; Ekegren Jenny K; Unge Johan; Unge Torsten; Wallberg Hans; Samuelsson Bertil; Hallberg Anders; Larhed Mats
Two-carbon-elongated HIV-1 protease inhibitors with a tertiary-alcohol-containing transition-state mimic.
Journal of medicinal chemistry 2008;51(4):1053-7.
2007: Bäck Marcus; Johansson Per-Ola; Wångsell Fredrik; Thorstensson Fredrik; Kvarnström Ingemar; Ayesa Susana; Wähling Horst; Pelcman Mikael; Jansson Katarina; Lindström Stefan; Wallberg Hans; Classon Björn; Rydergård Christina; Vrang Lotta; Hamelink Elizabeth; Hallberg Anders; Rosenquist Sa; Samuelsson Bertil
Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs.
Bioorganic & medicinal chemistry 2007;15(22):7184-202.
2007: Bjelic S; Nervall M; Gutiérrez-de-Terán H; Ersmark K; Hallberg A; Aqvist J
Computational inhibitor design against malaria plasmepsins.
Cellular and molecular life sciences : CMLS 2007;64(17):2285-305.
2007: Georgsson Jennie; Sköld Christian; Botros Milad; Lindeberg Gunnar; Nyberg Fred; Karlén Anders; Hallberg Anders; Larhed Mats
Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor.
Journal of medicinal chemistry 2007;50(7):1711-5.
2007: Thorstensson Fredrik; Wångsell Fredrik; Kvarnström Ingemar; Vrang Lotta; Hamelink Elizabeth; Jansson Katarina; Hallberg Anders; Rosenquist Sa; Samuelsson Bertil
Synthesis of novel potent hepatitis C virus NS3 protease inhibitors: discovery of 4-hydroxy-cyclopent-2-ene-1,2-dicarboxylic acid as a N-acyl-L-hydroxyproline bioisostere.
Bioorganic & medicinal chemistry 2007;15(2):827-38.
2006: Sköld Christian; Winiwarter Susanne; Wernevik Johan; Bergström Fredrik; Engström Leif; Allen Ruth; Box Karl; Comer John; Mole Jon; Hallberg Anders; Lennernäs Hans; Lundstedt Torbjörn; Ungell Anna-Lena; Karlén Anders
Presentation of a structurally diverse and commercially available drug data set for correlation and benchmarking studies.
Journal of medicinal chemistry 2006;49(23):6660-71.
2006: Rosenström Ulrika; Sköld Christian; Lindeberg Gunnar; Botros Milad; Nyberg Fred; Karlén Anders; Hallberg Anders
Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT1 and AT2 receptors.
Journal of medicinal chemistry 2006;49(20):6133-7.
2006: Gutiérrez-de-Terán Hugo; Nervall Martin; Ersmark Karolina; Liu Peng; Janka Linda K; Dunn Ben; Hallberg Anders; Aqvist Johan
Inhibitor binding to the plasmepsin IV aspartic protease from Plasmodium falciparum.
Biochemistry 2006;45(35):10529-41.
2006: Ersmark Karolina; Samuelsson Bertil; Hallberg Anders
Plasmepsins as potential targets for new antimalarial therapy.
Medicinal research reviews 2006;26(5):626-66.
2006: Georgsson Jennie; Rosenström Ulrika; Wallinder Charlotta; Beaudry Hélène; Plouffe Bianca; Lindeberg Gunnar; Botros Milad; Nyberg Fred; Karlén Anders; Gallo-Payet Nicole; Hallberg Anders
Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity.
Bioorganic & medicinal chemistry 2006;14(17):5963-72.
2006: Ekegren Jenny K; Gising Johan; Wallberg Hans; Larhed Mats; Samuelsson Bertil; Hallberg Anders
Variations of the P2 group in HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffold.
Organic & biomolecular chemistry 2006;4(16):3040-3.
2006: Johansson Per-Ola; Bäck Marcus; Kvarnström Ingemar; Jansson Katarina; Vrang Lotta; Hamelink Elizabeth; Hallberg Anders; Rosenquist Asa; Samuelsson Bertil
Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
Bioorganic & medicinal chemistry 2006;14(15):5136-51.
2006: Wannberg Johan; Sabnis Yogesh A; Vrang Lotta; Samuelsson Bertil; Karlén Anders; Hallberg Anders; Larhed Mats
A new structural theme in C2-symmetric HIV-1 protease inhibitors: ortho-substituted P1/P1' side chains.
Bioorganic & medicinal chemistry 2006;14(15):5303-15.
2006: Datta Gopal K; von Schenck Henrik; Hallberg Anders; Larhed Mats
Selective terminal heck arylation of vinyl ethers with aryl chlorides: a combined experimental-computational approach including synthesis of betaxolol.
The Journal of organic chemistry 2006;71(10):3896-903.
2006: Ersmark Karolina; Nervall Martin; Gutiérrez-de-Terán Hugo; Hamelink Elizabeth; Janka Linda K; Clemente Jose C; Dunn Ben M; Gogoll Adolf; Samuelsson Bertil; Qvist Johan; Hallberg Anders
Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IV.
Bioorganic & medicinal chemistry 2006;14(7):2197-208.
2006: Ekegren Jenny K; Ginman Nina; Johansson Asa; Wallberg Hans; Larhed Mats; Samuelsson Bertil; Unge Torsten; Hallberg Anders
Microwave-accelerated synthesis of P1'-extended HIV-1 protease inhibitors encompassing a tertiary alcohol in the transition-state mimicking scaffold.
Journal of medicinal chemistry 2006;49(5):1828-32.
2006: Arefalk Anna; Wannberg Johan; Larhed Mats; Hallberg Anders
Stereoselective synthesis of 3-aminoindan-1-ones and subsequent incorporation into HIV-1 protease inhibitors.
The Journal of organic chemistry 2006;71(3):1265-8.
2006: Rönn Robert; Sabnis Yogesh A; Gossas Thomas; Akerblom Eva; Danielson U Helena; Hallberg Anders; Johansson Anja
Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3.
Bioorganic & medicinal chemistry 2006;14(2):544-59.
2005: Ekegren Jenny K; Unge Torsten; Safa Mayada Zreik; Wallberg Hans; Samuelsson Bertil; Hallberg Anders
A new class of HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffold.
Journal of medicinal chemistry 2005;48(25):8098-102.
2005: Georgsson Jennie; Sköld Christian; Plouffe Bianca; Lindeberg Gunnar; Botros Milad; Larhed Mats; Nyberg Fred; Gallo-Payet Nicole; Gogoll Adolf; Karlén Anders; Hallberg Anders
Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity.
Journal of medicinal chemistry 2005;48(21):6620-31.
2005: Ersmark Karolina; Nervall Martin; Hamelink Elizabeth; Janka Linda K; Clemente Jose C; Dunn Ben M; Blackman Michael J; Samuelsson Bertil; Aqvist Johan; Hallberg Anders
Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulations.
Journal of medicinal chemistry 2005;48(19):6090-106.
2005: Muthas Daniel; Nöteberg Daniel; Sabnis Yogesh A; Hamelink Elizabeth; Vrang Lotta; Samuelsson Bertil; Karlén Anders; Hallberg Anders
Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II.
Bioorganic & medicinal chemistry 2005;13(18):5371-90.
2005: Wannberg Johan; Kaiser Nils-Fredrik K; Vrang Lotta; Samuelsson Bertil; Larhed Mats; Hallberg Anders
High-speed synthesis of potent C2-symmetric HIV-1 protease inhibitors by in-situ aminocarbonylations.
Journal of combinatorial chemistry 2005;7(4):611-7.
2005: Johansson Per-Ola; Lindberg Jimmy; Blackman Michael J; Kvarnström Ingemar; Vrang Lotta; Hamelink Elizabeth; Hallberg Anders; Rosenquist Asa; Samuelsson Bertil
Design and synthesis of potent inhibitors of plasmepsin I and II: X-ray crystal structure of inhibitor in complex with plasmepsin II.
Journal of medicinal chemistry 2005;48(13):4400-9.
2005: Rosenström Ulrika; Sköld Christian; Plouffe Bianca; Beaudry Hélène; Lindeberg Gunnar; Botros Milad; Nyberg Fred; Wolf Gunter; Karlén Anders; Gallo-Payet Nicole; Hallberg Anders
New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists.
Journal of medicinal chemistry 2005;48(12):4009-24.
2005: Svennebring Andreas; Garg Neeraj; Nilsson Peter; Hallberg Anders; Larhed Mats
A one-pot isomerization-arylation of 2,3-epoxycyclohexanone under controlled microwave heating.
The Journal of organic chemistry 2005;70(12):4720-5.
2005: Arefalk Anna; Larhed Mats; Hallberg Anders
Masked 3-aminoindan-1-ones by a palladium-catalyzed three-component annulation reaction.
The Journal of organic chemistry 2005;70(3):938-42.
2005: Ax Anna; Schaal Wesley; Vrang Lotta; Samuelsson Bertil; Hallberg Anders; Karlén Anders
Cyclic sulfamide HIV-1 protease inhibitors, with sidechains spanning from P2/P2' to P1/P1'.
Bioorganic & medicinal chemistry 2005;13(3):755-64.
2004: Lindberg Jimmy; Pyring David; Löwgren Seved; Rosenquist Asa; Zuccarello Guido; Kvarnström Ingemar; Zhang Hong; Vrang Lotta; Classon Björn; Hallberg Anders; Samuelsson Bertil; Unge Torsten
Symmetric fluoro-substituted diol-based HIV protease inhibitors. Ortho-fluorinated and meta-fluorinated P1/P1'-benzyloxy side groups significantly improve the antiviral activity and preserve binding efficacy.
European journal of biochemistry / FEBS 2004;271(22):4594-602.
2004: Johannesson Petra; Erdélyi Máté; Lindeberg Gunnar; Frändberg Per-Anders; Nyberg Fred; Karlén Anders; Hallberg Anders
AT2-selective angiotensin II analogues containing tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics.
Journal of medicinal chemistry 2004;47(24):6009-19.
2004: Wan Yiqian; Wallinder Charlotta; Plouffe Bianca; Beaudry Hélène; Mahalingam A K; Wu Xiongyu; Johansson Berndt; Holm Mathias; Botoros Milad; Karlén Anders; Pettersson Anders; Nyberg Fred; Fändriks Lars; Gallo-Payet Nicole; Hallberg Anders; Alterman Mathias
Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.
Journal of medicinal chemistry 2004;47(24):5995-6008.
2004: Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Hallberg A; Karlén A
Synthesis and AT2 receptor-binding properties of angiotensin II analogues.
The journal of peptide research : official journal of the American Peptide Society 2004;64(5):194-201.
2004: Johansson Per-Ola; Chen Yantao; Belfrage Anna Karin; Blackman Michael J; Kvarnström Ingemar; Jansson Katarina; Vrang Lotta; Hamelink Elizabeth; Hallberg Anders; Rosenquist Asa; Samuelsson Bertil
Design and synthesis of potent inhibitors of the malaria aspartyl proteases plasmepsin I and II. Use of solid-phase synthesis to explore novel statine motifs.
Journal of medicinal chemistry 2004;47(13):3353-66.
2004: Graffner-Nordberg Malin; Kolmodin Karin; Aqvist Johan; Queener Sherry F; Hallberg Anders
Design, synthesis, and computational affinity prediction of ester soft drugs as inhibitors of dihydrofolate reductase from Pneumocystis carinii.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2004;22(1):43-54.
2004: Poliakov Anton; Johansson Anja; Akerblom Eva; Oscarsson Karin; Samuelsson Bertil; Hallberg Anders; Danielson U Helena
Structure-activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors.
Biochimica et biophysica acta 2004;1672(1):51-9.
2004: Wan Yiqian; Wallinder Charlotta; Johansson Berndt; Holm Mathias; Mahalingam A K; Wu Xiongyu; Botros Milad; Karlén Anders; Pettersson Anders; Nyberg Fred; Fändriks Lars; Hallberg Anders; Alterman Mathias
First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivo.
Journal of medicinal chemistry 2004;47(6):1536-46.
2004: Rosenström Ulrika; Sköld Christian; Lindeberg Gunnar; Botros Milad; Nyberg Fred; Karlén Anders; Hallberg Anders
A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II.
Journal of medicinal chemistry 2004;47(4):859-70.
2004: Ersmark Karolina; Feierberg Isabella; Bjelic Sinisa; Hamelink Elizabeth; Hackett Fiona; Blackman Michael J; Hultén Johan; Samuelsson Bertil; Aqvist Johan; Hallberg Anders
Potent inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin D inhibitory activity.
Journal of medicinal chemistry 2004;47(1):110-22.
2003: Vallin Karl S A; Zhang Qisheng; Larhed Mats; Curran Dennis P; Hallberg Anders
A new regioselective Heck vinylation with enamides. Synthesis and investigation of fluorous-tagged bidentate ligands for fast separation.
The Journal of organic chemistry 2003;68(17):6639-45.
2003: Ersmark Karolina; Feierberg Isabella; Bjelic Sinisa; Hultén Johan; Samuelsson Bertil; Aqvist Johan; Hallberg Anders
C2-symmetric inhibitors of Plasmodium falciparum plasmepsin II: synthesis and theoretical predictions.
Bioorganic & medicinal chemistry 2003;11(17):3723-33.
2003: Dahlgren Anders; Kvarnström Ingemar; Vrang Lotta; Hamelink Elizabeth; Hallberg Anders; Rosenquist Asa; Samuelsson Bertil
New inhibitors of the malaria aspartyl proteases plasmepsin I and II.
Bioorganic & medicinal chemistry 2003;11(16):3423-37.
2003: Graffner-Nordberg Malin; Fyfe Meredith; Brattsand Ralph; Mellgård Björn; Hallberg Anders
Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis model.
Journal of medicinal chemistry 2003;46(16):3455-62.
2003: Georgsson Jennie; Hallberg Anders; Larhed Mats
Rapid palladium-catalyzed synthesis of esters from aryl halides utilizing Mo(CO)(6) as a solid carbon monoxide source.
Journal of combinatorial chemistry 2003;5(4):350-2.
2003: Oscarsson Karin; Poliakov Anton; Oscarson Stefan; Danielson U Helena; Hallberg Anders; Samuelsson Bertil
Peptide-based inhibitors of hepatitis C virus full-length NS3 (protease-helicase/NTPase): model compounds towards small molecule inhibitors.
Bioorganic & medicinal chemistry 2003;11(13):2955-63.
2003: Lindman Susanna; Lindeberg Gunnar; Frändberg Per-Anders; Nyberg Fred; Karlén Anders; Hallberg Anders
Effect of 3-5 monocyclizations of angiotensin II and 4-aminoPhe6-Ang II on AT2 receptor affinity.
Bioorganic & medicinal chemistry 2003;11(13):2947-54.
2003: Johansson Anja; Poliakov Anton; Akerblom Eva; Wiklund Karin; Lindeberg Gunnar; Winiwarter Susanne; Danielson U Helena; Samuelsson Bertil; Hallberg Anders
Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals.
Bioorganic & medicinal chemistry 2003;11(12):2551-68.
2003: Andersson Hans O; Fridborg Kerstin; Löwgren Seved; Alterman Mathias; Mühlman Anna; Björsne Magnus; Garg Neeraj; Kvarnström Ingmar; Schaal Wesley; Classon Björn; Karlén Anders; Danielsson U Helena; Ahlsén Göran; Nillroth Ullrika; Vrang Lotta; Oberg Bo; Samuelsson Bertil; Hallberg Anders; Unge Torsten
Optimization of P1-P3 groups in symmetric and asymmetric HIV-1 protease inhibitors.
European journal of biochemistry / FEBS 2003;270(8):1746-58.
2003: Oscarsson Karin; Oscarson Stefan; Vrang Lotta; Hamelink Elizabeth; Hallberg Anders; Samuelsson Bertil
New potent C2-symmetric malaria plasmepsin I and II inhibitors.
Bioorganic & medicinal chemistry 2003;11(7):1235-46.
2003: Nilsson Peter; Larhed Mats; Hallberg Anders
A new highly asymmetric chelation-controlled heck arylation.
Journal of the American Chemical Society 2003;125(12):3430-1.
2003: Wan Yiqian; Alterman Mathias; Larhed Mats; Hallberg Anders
Formamide as a combined ammonia synthon and carbon monoxide source in fast palladium-catalyzed aminocarbonylations of aryl halides.
Journal of combinatorial chemistry 2003;5(2):82-4.
2003: Oscarsson Karin; Lahmann Martina; Lindberg Jimmy; Kangasmetsä Jussi; Unge Torsten; Oscarson Stefan; Hallberg Anders; Samuelsson Bertil
Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2'-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complex.
Bioorganic & medicinal chemistry 2003;11(6):1107-15.
2003: Schmidt Boris; Kühn Christian; Ehlert Dennis K; Lindeberg Gunnar; Lindman Susanna; Karlén Anders; Hallberg Anders
A frame shifted disulfide bridged analogue of angiotensin II.
Bioorganic & medicinal chemistry 2003;11(6):985-90.
2003: Dahlgren Anders; Kvarnström Ingemar; Vrang Lotta; Hamelink Elizabeth; Hallberg Anders; Rosenquist Asa; Samuelsson Bertil
Solid-phase library synthesis of reversed-statine type inhibitors of the malarial aspartyl proteases plasmepsin I and II.
Bioorganic & medicinal chemistry 2003;11(6):827-41.
2003: Nöteberg Daniel; Hamelink Elizabeth; Hultén Johan; Wahlgren Mats; Vrang Lotta; Samuelsson Bertil; Hallberg Anders
Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes.
Journal of medicinal chemistry 2003;46(5):734-46.
2003: Winiwarter Susanne; Ax Fredrik; Lennernäs Hans; Hallberg Anders; Pettersson Curt; Karlén Anders
Hydrogen bonding descriptors in the prediction of human in vivo intestinal permeability.
Journal of molecular graphics & modelling 2003;21(4):273-87.
2002: Markgren Per-Olof; Schaal Wesley; Hämäläinen Markku; Karlén Anders; Hallberg Anders; Samuelsson Bertil; Danielson U Helena
Relationships between structure and interaction kinetics for HIV-1 protease inhibitors.
Journal of medicinal chemistry 2002;45(25):5430-9.
2002: Johansson Anja; Poliakov Anton; Akerblom Eva; Lindeberg Gunnar; Winiwarter Susanne; Samuelsson Bertil; Danielson U Helena; Hallberg Anders
Tetrapeptides as potent protease inhibitors of Hepatitis C Virus full-length NS3 (protease-helicase/NTPase).
Bioorganic & medicinal chemistry 2002;10(12):3915-22.
2002: Larhed Mats; Moberg Christina; Hallberg Anders
Microwave-accelerated homogeneous catalysis in organic chemistry.
Accounts of chemical research 2002;35(9):717-27.
2002: Vallin Karl S A; Emilsson Per; Larhed Mats; Hallberg Anders
High-speed heck reactions in ionic liquid with controlled microwave heating.
The Journal of organic chemistry 2002;67(17):6243-6.
2002: Wan Yiqian; Alterman Mathias; Larhed Mats; Hallberg Anders
Dimethylformamide as a carbon monoxide source in fast palladium-catalyzed aminocarbonylations of aryl bromides.
The Journal of organic chemistry 2002;67(17):6232-5.
2002: Bengtson Anna; Larhed Mats; Hallberg Anders
Protected indanones by a Heck-aldol annulation reaction.
The Journal of organic chemistry 2002;67(16):5854-6.
2002: Johannesson Petra; Lindeberg Gunnar; Johansson Anja; Nikiforovich Gregory V; Gogoll Adolf; Synnergren Barbro; Le Grèves Madeleine; Nyberg Fred; Karlén Anders; Hallberg Anders
Vinyl sulfide cyclized analogues of angiotensin II with high affinity and full agonist activity at the AT(1) receptor.
Journal of medicinal chemistry 2002;45(9):1767-77.
2002: Bengtson Anna; Hallberg Anders; Larhed Mats
Fast synthesis of aryl triflates with controlled microwave heating.
Organic letters 2002;4(7):1231-3.
2002: Kaiser Nils-Fredrik K; Hallberg Anders; Larhed Mats
In situ generation of carbon monoxide from solid molybdenum hexacarbonyl. A convenient and fast route to palladium-catalyzed carbonylation reactions.
Journal of combinatorial chemistry 2002;4(2):109-11.
2002: Ahlsén G; Hultén J; Shuman C F; Poliakov A; Lindgren M T; Alterman M; Samuelsson B; Hallberg A; Danielson U H
Resistance profiles of cyclic and linear inhibitors of HIV-1 protease.
Antiviral chemistry & chemotherapy 2002;13(1):27-37.
2001: Mühlman A; Lindberg J; Classon B; Unge T; Hallberg A; Samuelsson B
Synthesis of novel, potent, diol-based HIV-1 protease inhibitors via intermolecular pinacol homocoupling of (2S)-2-benzyloxymethyl-4-phenylbutanal.
Journal of medicinal chemistry 2001;44(21):3407-16.
2001: Mühlman A; Classon B; Hallberg A; Samuelsson B
Synthesis of potent C(2)-symmetric, diol-based hiv-1 protease inhibitors. Investigation of thioalkyl and thioaryl P1/P1' substituents.
Journal of medicinal chemistry 2001;44(21):3402-6.
2001: Pyring D; Lindberg J; Rosenquist A; Zuccarello G; Kvarnström I; Zhang H; Vrang L; Unge T; Classon B; Hallberg A; Samuelsson B
Design and synthesis of potent C(2)-symmetric diol-based HIV-1 protease inhibitors: effects of fluoro substitution.
Journal of medicinal chemistry 2001;44(19):3083-91.
2001: Nilsson P; Larhed M; Hallberg A
Highly regioselective, sequential, and multiple palladium-catalyzed arylations of vinyl ethers carrying a coordinating auxiliary: an example of a Heck triarylation process.
Journal of the American Chemical Society 2001;123(34):8217-25.
2001: Graffner-Nordberg M; Kolmodin K; Aqvist J; Queener S F; Hallberg A
Design, synthesis, computational prediction, and biological evaluation of ester soft drugs as inhibitors of dihydrofolate reductase from Pneumocystis carinii.
Journal of medicinal chemistry 2001;44(15):2391-402.
2001: Vallin K S; Larhed M; Hallberg A
Aqueous DMF-potassium carbonate as a substitute for thallium and silver additives in the palladium-catalyzed conversion of aryl bromides to acetyl arenes.
The Journal of organic chemistry 2001;66(12):4340-3.
2001: Alterman M; Sjöbom H; Säfsten P; Markgren P O; Danielson U H; Hämäläinen M; Löfås S; Hultén J; Classon B; Samuelsson B; Hallberg A
P1/P1' modified HIV protease inhibitors as tools in two new sensitive surface plasmon resonance biosensor screening assays.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2001;13(2):203-12.
2001: Lindman S; Lindeberg G; Gogoll A; Nyberg F; Karlén A; Hallberg A
Synthesis, receptor binding affinities and conformational properties of cyclic methylenedithioether analogues of angiotensin II.
Bioorganic & medicinal chemistry 2001;9(3):763-72.
2001: Olofsson K; Sahlin H; Larhed M; Hallberg A
Regioselective palladium-catalyzed synthesis of beta-arylated primary allylamine equivalents by an efficient Pd-N coordination.
The Journal of organic chemistry 2001;66(2):544-9.
2001: Johansson A; Hubatsch I; Akerblom E; Lindeberg G; Winiwarter S; Danielson U H; Hallberg A
Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain.
Bioorganic & medicinal chemistry letters 2001;11(2):203-6.
2001: Schaal W; Karlsson A; Ahlsén G; Lindberg J; Andersson H O; Danielson U H; Classon B; Unge T; Samuelsson B; Hultén J; Hallberg A; Karlén A
Synthesis and comparative molecular field analysis (CoMFA) of symmetric and nonsymmetric cyclic sulfamide HIV-1 protease inhibitors.
Journal of medicinal chemistry 2001;44(2):155-69.
2000: Hämäläinen M D; Markgren P O; Schaal W; Karlén A; Classon B; Vrang L; Samuelsson B; Hallberg A; Danielson U H
Characterization of a set of HIV-1 protease inhibitors using binding kinetics data from a biosensor-based screen.
Journal of biomolecular screening : the official journal of the Society for Biomolecular Screening 2000;5(5):353-60.
2000: Graffner-Nordberg M; Marelius J; Ohlsson S; Persson A; Swedberg G; Andersson P; Andersson S E; Aqvist J; Hallberg A
Computational predictions of binding affinities to dihydrofolate reductase: synthesis and biological evaluation of methotrexate analogues.
Journal of medicinal chemistry 2000;43(21):3852-61.
2000: Johansson A; Akerblom E; Ersmark K; Lindeberg G; Hallberg A
An improved procedure for N- to C-directed (Inverse) solid-phase peptide synthesis.
Journal of combinatorial chemistry 2000;2(5):496-507.
2000: Lindman S; Lindeberg G; Nyberg F; Karlén A; Hallberg A
Comparison of three gamma-turn mimetic scaffolds incorporated into angiotensin II.
Bioorganic & medicinal chemistry 2000;8(9):2375-83.
2000: Lindström S; Ripa L; Hallberg A
Synthesis of two conformationally constrained analogues of the minor tobacco alkaloid anabasine.
Organic letters 2000;2(15):2291-3.
1999: Johannesson P; Lindeberg G; Tong W; Gogoll A; Synnergren B; Nyberg F; Karlén A; Hallberg A
Angiotensin II analogues encompassing 5,9- and 5,10-fused thiazabicycloalkane tripeptide mimetics.
Journal of medicinal chemistry 1999;42(22):4524-37.
1999: Hultén J; Andersson H O; Schaal W; Danielson H U; Classon B; Kvarnström I; Karlén A; Unge T; Samuelsson B; Hallberg A
Inhibitors of the C(2)-symmetric HIV-1 protease: nonsymmetric binding of a symmetric cyclic sulfamide with ketoxime groups in the P2/P2' side chains.
Journal of medicinal chemistry 1999;42(20):4054-61.
1999: Alterman M; Andersson H O; Garg N; Ahlsén G; Lövgren S; Classon B; Danielson U H; Kvarnström I; Vrang L; Unge T; Samuelsson B; Hallberg A
Design and fast synthesis of C-terminal duplicated potent C(2)-symmetric P1/P1'-modified HIV-1 protease inhibitors.
Journal of medicinal chemistry 1999;42(19):3835-44.
1999: Johannesson P; Lindeberg G; Tong W; Gogoll A; Karlén A; Hallberg A
Bicyclic tripeptide mimetics with reverse turn inducing properties.
Journal of medicinal chemistry 1999;42(4):601-8.
1998: Winiwarter S; Bonham N M; Ax F; Hallberg A; Lennernäs H; Karlén A
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
Journal of medicinal chemistry 1998;41(25):4939-49.
1998: Alterman M; Björsne M; Mühlman A; Classon B; Kvarnström I; Danielson H; Markgren P O; Nillroth U; Unge T; Hallberg A; Samuelsson B
Design and synthesis of new potent C2-symmetric HIV-1 protease inhibitors. Use of L-mannaric acid as a peptidomimetic scaffold.
Journal of medicinal chemistry 1998;41(20):3782-92.
1998: Graffner-Nordberg M; Sjödin K; Tunek A; Hallberg A
Synthesis and enzymatic hydrolysis of esters, constituting simple models of soft drugs.
Chemical & pharmaceutical bulletin 1998;46(4):591-601.
1998: Marelius J; Graffner-Nordberg M; Hansson T; Hallberg A; Aqvist J
Computation of affinity and selectivity: binding of 2,4-diaminopteridine and 2,4-diaminoquinazoline inhibitors to dihydrofolate reductases.
Journal of computer-aided molecular design 1998;12(2):119-31.
1997: Nillroth U; Vrang L; Markgren P O; Hultén J; Hallberg A; Danielson U H
Human immunodeficiency virus type 1 proteinase resistance to symmetric cyclic urea inhibitor analogs.
Antimicrobial agents and chemotherapy 1997;41(11):2383-8.
1997: Schmidt B; Lindman S; Tong W; Lindeberg G; Gogoll A; Lai Z; Thörnwall M; Synnergren B; Nilsson A; Welch C J; Sohtell M; Westerlund C; Nyberg F; Karlén A; Hallberg A
Design, synthesis, and biological activities of four angiotensin II receptor ligands with gamma-turn mimetics replacing amino acid residues 3-5.
Journal of medicinal chemistry 1997;40(6):903-19.
1997: Bäckbro K; Löwgren S; Osterlund K; Atepo J; Unge T; Hultén J; Bonham N M; Schaal W; Karlén A; Hallberg A
Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitor.
Journal of medicinal chemistry 1997;40(6):898-902.
1997: Hultén J; Bonham N M; Nillroth U; Hansson T; Zuccarello G; Bouzide A; Aqvist J; Classon B; Danielson U H; Karlén A; Kvarnström I; Samuelsson B; Hallberg A
Cyclic HIV-1 protease inhibitors derived from mannitol: synthesis, inhibitory potencies, and computational predictions of binding affinities.
Journal of medicinal chemistry 1997;40(6):885-97.
1995: Särnstrand B; Tunek A; Sjödin K; Hallberg A
Effects of N-acetylcysteine stereoisomers on oxygen-induced lung injury in rats.
Chemico-biological interactions 1995;94(2):157-64.
1994: Engman L; Tunek A; Hallberg M; Hallberg A
Catalytic effects of glutathione peroxidase mimetics on the thiol reduction of cytochrome c.
Chemico-biological interactions 1994;93(2):129-37.
1994: Andersson C M; Brattsand R; Hallberg A; Engman L; Persson J; Moldéus P; Cotgreave I
Diaryl tellurides as inhibitors of lipid peroxidation in biological and chemical systems.
Free radical research 1994;20(6):401-10.
1994: Andersson C M; Hallberg A; Linden M; Brattsand R; Moldéus P; Cotgreave I
Antioxidant activity of some diarylselenides in biological systems.
Free radical biology & medicine 1994;16(1):17-28.
1992: Cotgreave I A; Moldéus P; Brattsand R; Hallberg A; Andersson C M; Engman L
Alpha-(phenylselenenyl)acetophenone derivatives with glutathione peroxidase-like activity. A comparison with ebselen.
Biochemical pharmacology 1992;43(4):793-802.
1991: Cotgreave I A; Moldéus P; Engman L; Hallberg A
The correlation of the oxidation potentials of structurally related dibenzo[1,4]dichalcogenines to their antioxidance capacity in biological systems undergoing free radical-induced lipid peroxidation.
Biochemical pharmacology 1991;42(7):1481-5.
1991: Nilsson K; Hallberg A; Pileblad E; Tunek A
Investigation of the possible dopaminergic toxicity of 1-methyl-3-phenyl-1,2,3,6-tetrahydropyridine, an isomer to the neurotoxin MPTP.
Pharmacology & toxicology 1991;69(1):38-42.
1989: Sjödin K; Nilsson E; Hallberg A; Tunek A
Metabolism of N-acetyl-L-cysteine. Some structural requirements for the deacetylation and consequences for the oral bioavailability.
Biochemical pharmacology 1989;38(22):3981-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Anders Hallberg

Research Profile (preview)

Concepts & Ideas

Chemicals & Drugs

Procedures

Living Beings

Physiology

Occupations

Anatomy

Genes & Molecular Sequences

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Anders Hallberg (preview)

All Publications